Halliburton Work in process increased by 9.7% to $136.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.9%, from $140.00M to $136.00M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 13.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $80.00M | $86.00M | $91.00M | $113.00M | $123.00M | $124.00M | $111.00M | $127.00M | $129.00M | $137.00M | $136.00M | $141.00M | $149.00M | $144.00M | $132.00M | $140.00M | $136.00M | $135.00M | $124.00M | $136.00M |
| QoQ Change | — | +7.5% | +5.8% | +24.2% | +8.8% | +0.8% | -10.5% | +14.4% | +1.6% | +6.2% | -0.7% | +3.7% | +5.7% | -3.4% | -8.3% | +6.1% | -2.9% | -0.7% | -8.1% | +9.7% |
| YoY Change | — | — | — | — | +53.8% | +44.2% | +22.0% | +12.4% | +4.9% | +10.5% | +22.5% | +11.0% | +15.5% | +5.1% | -2.9% | -0.7% | -8.7% | -6.3% | -6.1% | -2.9% |
| % of Inventories | 3.4% | 3.7% | 3.9% | 4.4% | 4.6% | 4.4% | 3.8% | 4.1% | 4.0% | 4.1% | 4.2% | 4.3% | 4.5% | 4.5% | 4.3% | 4.6% | 4.4% | 4.4% | 4.2% | 4.5% |
| Share Change | — | +0.3pp | +0.2pp | +0.5pp | +0.3pp | -0.3pp | -0.6pp | +0.3pp | -0.1pp | +0.1pp | +0.1pp | +0.1pp | +0.2pp | -0.0pp | -0.2pp | +0.3pp | -0.2pp | -0.1pp | -0.2pp | +0.3pp |